Pages
Posts by category
- Category: Archives News
- Category: News - Press
- Palmarès de l’innovation : l’Inserm se distingue une nouvelle fois par son dynamisme et ses résultats
- 2èmes rencontres du parcours pré-entrepreneurial : Inserm Transfert dévoile de nouveaux dispositifs de soutien à la création d’entreprise de croissance
- L’Inserm, Inserm Transfert et la SATT Toulouse Tech Transfer (TTT) signent un accord de partenariat pour le financement de projets de maturation à Toulouse
- RaDiCo (Inserm) et Boehringer Ingelheim France annoncent un partenariat autour de la Fibrose Pulmonaire Idiopathique
- Un modèle animal inédit pour accélérer la lutte contre la maladie d’Alzheimer
- OSE Immunotherapeutics annonce un accord de collaboration avec option de licence avec l’Inserm sur une nouvelle immunothérapie du cancer ciblant les cellules myéloïdes
- MedImmune, Inserm and Inserm Transfert Renew Strategic Research Partnership
- ILiAD Biotechnologies BPZE1 Pertussis Vaccine Reaches Key Milestones including Positive Phase 1b Clinical Study Data
- TxCell and Inserm collaborate to develop new CAR-Tregs in transplantation and multiple sclerosis
- Classement 2016 de l’Office européen des brevets: doublé gagnant pour l’Inserm
- Prévention et traitement des accidents vasculaires : MSDAVENIR, l’AP-HP et l’Inserm signent deux conventions de financement pour les programmes de recherche SAVE BRAIN et SURVI
- Projet CARBAMAT : vers une avancée médicale pour limiter la résistance aux antibiotiques
- Stimunity signs an Exclusive License Agreement with Institut Curie and Inserm
- MSD France and Lille University Regional Hospital Centre supported by Inserm Transfert sign a partnership agreement on the FREGAT Clinical-Biological database to improve the management of patients suffering from oesophago-gastric cancers.
- “SANOFI-INSERM HBV Cure program”: a medical, academic and pharmaceutical alliance for research into hepatitis B
- Jean-Laurent Casanova, specialist in genetics of infectious diseases, winner of the Inserm Grand Prix 2016 prize.
- TxCell acquires the exclusive worldwide rights on a new population of regulatory T cells from Inserm Transfert.
- Pierre Fabre and Cordeliers Research Centre Enter into strategic partnership to identify new therapeutic targets in immuno-oncology
- NAREB: a EU-funded research project for combating antibiotic resistance
- Quest Diagnostics and Inserm Launch Multinational BRCA Gene Datashare Initiative, with LabCorp as First Participant, to Improve the Detection of Inherited Risk of Breast and Ovarian Cancers
- Creation of HalioDx
- European Patent Office rankings for 2014: Inserm 6th in France for patent applications, 1st in Europe for academic patent applications in biomedical research
- Advanced Biological Laboratories Enters into Worldwide Exclusive License Agreement for HIV Tropism Determination Technology with Inserm and Inserm Transfert SA, and the Centre Hospitalier Universitaire de Toulouse
- Huntington’s disease: therapeutic potential of triheptanoin confirmed
- Christos Chatziantoniou at Inserm UMR 1155 Wins GSK’s Discovery Fast Track Challenge to Investigate Chronic Kidney Disease
- Inserm Transfert (France) and Translational Research Informatics Center (Japan) enter into international cooperation agreement regarding translational researches
- Cécile Tharaud appointed as President and Managing Partner of Inserm Transfert Initiative
- Mrs Pascale Augé appointed as Chief Executive Officer, Inserm Transfert
- ILiAD Biotechnologies, Inserm and Inserm Transfert SA, and Institut Pasteur de Lille Enter Scientific Collaboration and Worldwide License Agreements for Vaccine Technology
- Inserm Transfert and GSK sign a worldwide license agreement on novel immune checkpoint modulators for the treatment of cancer
- DBV Technologies Forms Research Collaboration with Inserm to Develop Viaskin® for Refractory Hemophilia A Disease
- Inserm Transfert and MassBio announce a partnership to foster innovation, technology transfer and entrepreneurship between France and Massachusetts (USA)
- QIAGEN Marseille acquires exclusive rights from Inserm Transfert SA and Inserm on HSP110 mutations for colorectal cancer
- Roche, Fondation FondaMental and Inserm partners to improve understanding of autism mechanims.
- Imagine Institute and GlaxoSmithKline (GSK) Agree on a Collaborative Partnership for Drug Discovery for rare diseases
- DBV Technologies and Centre d’Immunologie de MarseilleLuminy (CIML) enter in a Collaboration Agreement
- Launch of ENTENTE, the first European network to boost knowledge transfer activity in health research in academic and governmental organisations and industry-academia collaboration
- Sebia partners with Inserm and Inserm Transfert to develop a unique diagnostic test for haemoglobin diseases
- La cohorte CKD-REIN, financée dans le cadre du Programme Investissements d’avenir, fédère un partenariat avec 6 acteurs industriels majeurs dans le domaine de la néphrologie
- Roche, the French National Agency for Research on AIDS and Viral Hepatitis, Baylor Research Institute and Inserm Transfert Establish Strategic Collaboration to Develop Therapeutic Vaccines for Chronic Infectious Diseases
- Covance, Inserm Transfert SA, and Inserm Transfert Initiative Enter Four-Year Scientific Agreement
- “Investments for the future” program: Fonds National d’Amorçage’s first investment is in Inserm Transfert Initiative, a seed capital company specialising in life sciences and healthcare
- MEDIMMUNE, INSERM AND INSERM TRANSFERT ANNOUNCE STRATEGIC COLLABORATION TO FUND AND CONDUCT MEDICAL SCIENCE RESEARCH
- Inserm Transfert annonce 70% de taux de réussite au 4e appel à proposition du 7e PCRD et renforce son activité auprès de chercheurs internationaux
- Inserm Transfert annonce l’obtention de la certification Qualité ISO 9001-2008 pour ses activités de management de projets de recherche collaborative
- INSERM TRANSFERT AND INNATE PHARMA ENTER INTO AN INNOVATIVE PARTNERSHIP FOR THE DEVELOPMENT OF NEW ANTIBODIES FOR THE TREATMENT OF CANCER AND INFLAMMATORY OR AUTOIMMUNE DISEASES
Jobs
Portfolio
Job Categories
Job Types
Job Locations
Portfolio categories
